先天性心脏病宫内诊疗现状与展望  

Current research status and prospect on intrauterine diagnosis and treatment of congenital heart disease

作　　者：王濛 王華麟 王鉴[1] 孙锟[1] Meng Wang;Hualin Wang;Jian Wang;Kun Sun(Pediatric Heart Center,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200092,China)

机构地区：[1]上海交通大学医学院附属新华医院儿心脏中心,上海200092

出　　处：《中华妇幼临床医学杂志（电子版）》2024年第5期481-485,共5页Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)

基　　金：上海市卫生健康委协同创新集群计划项目(2020CXJQ01)。

摘　　要：先天性心脏病(CHD)是导致我国出生缺陷婴幼儿死亡的首要原因。CHD宫内诊疗体系,将危重CHD诊治窗口前移至胎儿期,有利于患儿的早期健康和远期预后。近30年来,国内外在CHD的产前诊断、宫内介入治疗、宫内诊疗体系建设等领域,均取得了重大进展。未来,CHD宫内诊疗技术的创新与其体系的完善,将进一步促进危重CHD的早诊、早治和规范管理,为儿童全生命周期健康发展提供保障。笔者拟对国内外CHD宫内诊疗现状进行阐述,并对中国CHD宫内诊疗的研究和发展方向进行展望,旨在为临床提高CHD儿童生命早期健康研究提供参考。Congenital heart disease(CHD)is the leading cause of death among infants with birth defects in China.The intrauterine diagnosis and treatment system for CHD advances the diagnosis and treatment window for severe CHD forward to fetal period,which is beneficial to the early health and long-term prognosis of CHD children.In the past 30 years,significant progress has been made in the fields of prenatal diagnosis,intrauterine intervention,and the establishment of intrauterine treatment systems for CHD at home and abroad.In the future,the innovation of CHD intrauterine diagnosis and treatment technology and improvement of its system will further promote the early diagnosis,early treatment and standardized management of severe CHD,and provide protection for healthy development of children throughout their life cycle.The authors intend to expound the latest research status of intrauterine diagnosis and treatment of CHD at home and abroad,and provide an outlook on intrauterine diagnosis and treatment of CHD in China,aiming to provide a reference for clinical research on improving early life health of CHD children.

关 键 词：先天性心脏病 宫内儿科学 宫内诊疗 生命早期 胎儿 

分 类 号：R541.1[医药卫生—心血管疾病]